Saturday, February 6, 2021
AstraZeneca COVID jab ‘less effective against S Africa variant’ | Coronavirus pandemic News
British drugmaker says its vaccine showed ‘limited efficacy against mild disease’ caused by the South African variant of the coronavirus. The COVID-19 vaccine developed by AstraZeneca and the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of the coronavirus, a spokesman for the British drugmaker has said. The statement on
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Threat actors are exploiting ProxyLogon and ProxyShell exploits in unpatched Microsoft Exchange Servers as part of an ongoing spam campaign
-
Venezuela used to be the richest country in Latin America, sitting on the world’s largest oil reserves. Yet Venezuelans are scrambling for m...
-
Following today’s news that Samsung and Apple have worked together to bring an iTunes Movies & TV app and AirPlay 2 support to 2018 and ...
No comments:
Post a Comment